User Name Password

back to homepage

London Capital (LCG.L) - concentration on tight spreads powers growth
LCG.L
Full Report by Objective Capital , May 18, 2007 (login for full report)
Questions? Contact our analyst

Key Points:

  • Capital Spreads continues to exceed the market’s 20%-25% p.a growth
    London Capital’s spread-betting arm continues to grow faster than its competitors, increasing turnover by 68% in 2006. We believe that this growth will continue in 2007, with the number of client accounts, the average number of trades per day and amounts on deposit all continuing to grow.

  • Scaleable business model
    The spread-betting business is highly scaleable as the platform can handle far more volume: a paperless system combines with a low-cost business model to ensure that Capital Spread’s existing headcount is ample to handle predicted growth. This is a business with high operational gearing: profit continues to expand faster than turnover.

  • Unique forex platform enables strong growth
    London Capital’s forex business, Capital Forex was launched in November 2005, with revenues in 2006 of £1.38m on minimal marketing. Volumes and ticket sizes are increasing every quarter. The business operates at low-risk: it takes no principal position and attracts institutional clients with low commissions. It does so by using an Electronic currency network (ECN) platform to stream prices and a major bank as clearer and credit provider. Capital Forex should continue to grow at rates well in excess of industry forecasts of 20% p.a. for the global foreign exchange market as a whole.

  • Low-risk business model
    London Capital operates a low-risk business model throughout: in spread-betting it offers no credit, taking a deposit and assigning automatic stop-loss limits as well as tight value at risk limits on all markets. In forex, the company takes no principal positions, but acts as a broker, reflecting tight spreads and liquidity to its clients through its platform. Derivatives broking is also an agency only business.

  • Overseas potential
    In addition to the growth offered by forex where London is the biggest market, new EU directives are to open up market spread-betting outside the UK. London Capital plans to address this through white-label partners. In addition, in the longer term, the anticipated decoupling of China’s currency from the US dollar, provided it is accompanied by the relaxing of exchange controls by China, could add a new dimension to the forex market.

Free registration required for full report

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer